ORAGENICS, INC. Common Stock, Capital Shares Reserved for Future Issuance
ORAGENICS, INC. (OGEN) had Common Stock, Capital Shares Reserved for Future Issuance of 1.81 million shares as of 2018-09-30, per its 10-Q filed 2018-11-13.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2018-11-13
- 2018-09-30: Common Stock, Capital Shares Reserved for Future Issuance 1.81M shares.
- 2017-12-31: Common Stock, Capital Shares Reserved for Future Issuance 264.62K shares.
- 2016-12-31: Common Stock, Capital Shares Reserved for Future Issuance 1.91M shares.
- 2015-12-31: Common Stock, Capital Shares Reserved for Future Issuance 2.12M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2018-09-30 | 1.81M shares 10-Q · filed 2018-11-13 |
| 2017-12-31 | 264.62K shares 10-K · filed 2018-02-16 |
| 2016-12-31 | 1.91M shares 10-K · filed 2017-02-27 |
| 2015-12-31 | 2.12M shares 10-K · filed 2016-03-30 |
| 2014-12-31 | 2.32M shares 10-K · filed 2015-02-27 |
| 2012-06-30 | 140.82K shares 10-Q · filed 2012-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |